66 related articles for article (PubMed ID: 18589127)
1. Effect of pretransplant hepatitis C virus RNA status on posttransplant outcome.
Nudo CG; Cortes RA; Weppler D; Schiff ER; Tzakis AG; Regev A
Transplant Proc; 2008 Jun; 40(5):1449-55. PubMed ID: 18589127
[TBL] [Abstract][Full Text] [Related]
2. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
[TBL] [Abstract][Full Text] [Related]
3. Humoral immune response to hepatitis C after liver transplantation: assessment of a new recombinant immunoblot assay.
Rosen HR; Gretch D; Kaufman E; Quan S
Am J Gastroenterol; 2000 Aug; 95(8):2035-9. PubMed ID: 10950054
[TBL] [Abstract][Full Text] [Related]
4. HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma.
De Martin E; Senzolo M; Boninsegna S; Guido M; Masier A; Germani G; Tomat S; Brolese A; Neri D; Cillo U; Gambato M; Russo FP; Farinati F; Burra P
Transplant Proc; 2008; 40(6):1974-5. PubMed ID: 18675104
[TBL] [Abstract][Full Text] [Related]
5. Long-term immune response after liver transplantation in patients with spontaneous or post-treatment HCV-RNA clearance.
Casanovas-Taltavull T; Ercilla MG; Gonzalez CP; Gil E; Viñas O; Cañas C; Casanova A; Figueras J; Serrano T; Casais LA
Liver Transpl; 2004 May; 10(5):584-94. PubMed ID: 15108249
[TBL] [Abstract][Full Text] [Related]
6. Histological recurrent hepatitis C after liver transplantation: Outcome and role of retransplantation.
Ercolani G; Grazi GL; Ravaioli M; Del Gaudio M; Cescon M; Varotti G; Ramacciato G; Vetrone G; Zanello M; Pinna AD
Liver Transpl; 2006 Jul; 12(7):1104-11. PubMed ID: 16710855
[TBL] [Abstract][Full Text] [Related]
7. Does interferon use prior to liver transplant influence hepatitis C outcomes following transplantation?
Smallwood GA; Devine R; Fasola C; Stieber AC; Heffron TG
Transplantation; 2008 Dec; 86(12):1795-8. PubMed ID: 19104424
[TBL] [Abstract][Full Text] [Related]
8. Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation.
D'Errico-Grigioni A; Fiorentino M; Vasuri F; Gruppioni E; Fabbrizio B; Zucchini N; Ballardini G; Morelli C; Pinna AD; Grigioni WF
Liver Transpl; 2008 Mar; 14(3):313-20. PubMed ID: 18306349
[TBL] [Abstract][Full Text] [Related]
9. The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C.
Yagci G; Fernandez LA; Knechtle SJ; D'Alessandro AM; Chin LT; Musat AI; Lucey MR; Said A; Pirsch JD; Leverson G; Kalayoglu M
Transplant Proc; 2008; 40(1):219-23. PubMed ID: 18261591
[TBL] [Abstract][Full Text] [Related]
10. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis.
Briceño J; Ciria R; Pleguezuelo M; de la Mata M; Muntané J; Naranjo A; Sánchez-Hidalgo J; Marchal T; Rufián S; López-Cillero P
Liver Transpl; 2009 Jan; 15(1):37-48. PubMed ID: 19109846
[TBL] [Abstract][Full Text] [Related]
11. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
Yosry A; Esmat G; El-Serafy M; Omar A; Doss W; Said M; Abdel-Bary A; Hosny A; Marawan I; El-Malt O; Kamel RR; Hatata Y; Ghali A; Sabri H; Kamel S; El-Gbaly H; Tanaka K
Transplant Proc; 2008 Jun; 40(5):1481-4. PubMed ID: 18589133
[TBL] [Abstract][Full Text] [Related]
12. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
Raziorrouh B; Jung MC; Schirren CA; Loehe F; Thiel M; Nitschko H; Diepolder H; Ulsenheimer A; Heeg M; Zachoval R; Gruener NH
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):778-83. PubMed ID: 18617783
[TBL] [Abstract][Full Text] [Related]
13. Comparison of hepatitis C histological recurrence rates and patient survival between split and deceased donor liver transplantation.
Lawal A; Ghobrial R; Te H; Artinian L; Eastwood D; Schiano TD
Transplant Proc; 2007 Dec; 39(10):3261-5. PubMed ID: 18089367
[TBL] [Abstract][Full Text] [Related]
14. Scarce influence of corticosteroid boluses on long-term viral load and liver histology in transplanted patients with recurrent hepatitis C.
Barcena R; Oton E; Barreales M; Castillo M; Blesa C
Transplant Proc; 2006 Oct; 38(8):2502-4. PubMed ID: 17097981
[TBL] [Abstract][Full Text] [Related]
15. Elevated CD4+/CD25+ T-cell frequency and function during hepatitis C virus recurrence after liver transplantation.
Perrella A; Arenga G; Pisaniello D; Rampone B; Di Costanzo GG; Atripaldi L; Esposito C; Di Florio E; Perrella O; Cuomo O
Transplant Proc; 2009 Jun; 41(5):1761-6. PubMed ID: 19545723
[TBL] [Abstract][Full Text] [Related]
16. Outcome of combined liver and kidney transplantation in hepatitis C: a single-center long-term follow-up experience.
del Pozo AC; Martín JD; Rodriguez-Laiz G; Sturdevant M; Iyer K; Schwartz M; Schiano T; Lerner S; Ames S; Bromberg J; Thung S; de Boccardo G
Transplant Proc; 2009 Jun; 41(5):1713-6. PubMed ID: 19545713
[TBL] [Abstract][Full Text] [Related]
17. Predictors of sustained virological response after antiviral treatment for hepatitis C recurrence following liver transplantation.
Cescon M; Grazi GL; Cucchetti A; Vetrone G; Ravaioli M; Ercolani G; Morelli MC; Piscaglia F; Tamè M; Pinna AD
Liver Transpl; 2009 Jul; 15(7):782-9. PubMed ID: 19562715
[TBL] [Abstract][Full Text] [Related]
18. Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival.
Ghabril M; Dickson RC; Machicao VI; Aranda-Michel J; Keaveny A; Rosser B; Bonatti H; Krishna M; Yataco M; Satyanarayana R; Harnois D; Hewitt W; Willingham DD; Grewal H; Hughes CB; Nguyen J
Liver Transpl; 2007 Dec; 13(12):1717-27. PubMed ID: 18044750
[TBL] [Abstract][Full Text] [Related]
19. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
Aguilera V; Berenguer M; Rubín A; San-Juan F; Rayón JM; Prieto M; Mir J
Liver Transpl; 2009 Jan; 15(1):79-87. PubMed ID: 19109849
[TBL] [Abstract][Full Text] [Related]
20. Impact of anti-hepatitis C virus (HCV) antibody on outcomes in renal transplant recipients infected with HCV.
Minz M; Sharma A; Das A; Chawla Y
Transplant Proc; 2008 Sep; 40(7):2386-8. PubMed ID: 18790242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
